BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 38455709)

  • 1. A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review.
    Mazza M; Arcidiacono GP; Hoxhaj I; Padoan V; Tasca G; Burei M; Sella S; Simioni P; Giannini S; Mocellin S
    Calcif Tissue Int; 2024 May; ():. PubMed ID: 38806758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced osteomalacia: A systematic literature review.
    Álvarez-Rivas N; Lugo-Rodríguez G; Maneiro JR; Iñiguez-Ubiaga C; Melero-Gonzalez RB; Iglesias-Cabo T; Carmona L; García-Porrúa C; de Toro-Santos FJ
    Bone Rep; 2024 Jun; 21():101772. PubMed ID: 38774264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphaturic mesenchymal tumor: Clinicopathological features with outcomes in 10 patients with review of literature.
    Parameshwar VC; Rekhi B; Duggad A; Ramadwar M
    Indian J Pathol Microbiol; 2024 Apr; 67(2):306-311. PubMed ID: 38394416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
    Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphaturic mesenchymal tumors: what an endocrinologist should know.
    Boland JM; Tebben PJ; Folpe AL
    J Endocrinol Invest; 2018 Oct; 41(10):1173-1184. PubMed ID: 29446010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphaturic mesenchymal tumor with
    Dwabe S; Chow W
    Ther Adv Med Oncol; 2024; 16():17588359241232092. PubMed ID: 38455709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.
    Ghorbani-Aghbolaghi A; Darrow MA; Wang T
    Autops Case Rep; 2017; 7(3):32-37. PubMed ID: 29043208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphaturic Mesenchymal Tumor in the Proximal Femur Presenting as Tumor-induced Osteomalacia: A Case Report and Literature Review.
    Tungenwar S; Subith S; Mukadam M; Kokate S; Gunay S
    J Orthop Case Rep; 2024 Feb; 14(2):23-28. PubMed ID: 38420233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced osteomalacia treated with T12 tumor resection.
    Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
    Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
    Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphaturic Mesenchymal Tumors with or without Phosphate Metabolism Derangements.
    Montanari A; Pirini MG; Lotrecchiano L; Di Prinzio L; Zavatta G
    Curr Oncol; 2023 Aug; 30(8):7478-7488. PubMed ID: 37623022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
    Wang H; Zhang J; Li H; Yu H; Chen S; Liu S; Zhang C; He Y
    Front Oncol; 2022; 12():918719. PubMed ID: 36081567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review.
    Oyama N; Kojima-Ishii K; Toda N; Matsuo T; Tocan V; Ohkubo K; Oba U; Koga Y; Setsu N; Yamada Y; Kohashi K; Nakashima Y; Oda Y; Ihara K; Ohga S
    Clin Pediatr Endocrinol; 2020; 29(2):69-75. PubMed ID: 32313375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burosumab in X-linked hypophosphatemia: a profile of its use in the USA.
    Lyseng-Williamson KA
    Drugs Ther Perspect; 2018; 34(11):497-506. PubMed ID: 30459508
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.